XML 98 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaborative Arrangements - Bayer AG (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 64,168 $ 60,115 $ 59,283
Cost of sales 15,193 16,126 17,411
Selling, general and administrative 10,816 10,504 10,042
Research and development 17,938 30,531 13,548
Other current assets 38,782 32,168  
Accrued and other current liabilities 15,694 15,766  
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Milestone payments sales-based     400
Revenue from collaborative arrangement 415 367 341
Sales 739 658 601
Cost of sales 244 224 210
Selling, general and administrative 111 131 153
Research and development 102 90 75
Other current assets 160 156  
Accrued and other current liabilities 82 80  
Licenses and other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Intangible assets 3,091 3,212  
Adempas | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 287 255 238
Adempas | Licenses and other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Intangible assets 372    
Verquvo | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 37 $ 36 $ 22
Verquvo | Licenses and other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Intangible assets $ 42